Effects of nafamostat mesilate anticoagulant on continuous renal replacement therapy in patients at high risk of bleeding after cardiovascular surgery

ZHOU Wei, TAO Yun, HAN Lin, XU Zhiyun, LI Bailing, CHENG Hao

PDF(1465 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1465 KB)
World Clinical Drug ›› 2022, Vol. 43 ›› Issue (09) : 1143-1147. DOI: 10.13683/j.wph.2022.09.011114
Article

Effects of nafamostat mesilate anticoagulant on continuous renal replacement therapy in patients at high risk of bleeding after cardiovascular surgery

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 43(09): 1143-1147 https://doi.org/10.13683/j.wph.2022.09.011114

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1465 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉